Atlas Biolabs Accredited as CSP for Affymetrix's DMET Plus | GenomeWeb

NEW YORK (GenomeWeb News) – German molecular genetics analysis firm Atlas Biolabs today said that it has been accredited as a Certified Service Provider for Affymetrix's DMET Plus Solution.

Atlas said it is the first European Certified Service Provider to offer the DMET technology for molecular pharmacogenetics in Germany.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.